These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21866548)

  • 1. Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistry.
    Laerum OD; Ovrebo K; Skarstein A; Christensen IJ; Alpízar-Alpízar W; Helgeland L; Danø K; Nielsen BS; Illemann M
    Int J Cancer; 2012 Aug; 131(3):558-69. PubMed ID: 21866548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase plasminogen activator receptor on invasive cancer cells: a prognostic factor in distal gastric adenocarcinoma.
    Alpízar-Alpízar W; Christensen IJ; Santoni-Rugiu E; Skarstein A; Ovrebo K; Illemann M; Laerum OD
    Int J Cancer; 2012 Aug; 131(4):E329-36. PubMed ID: 21901747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder.
    Dohn LH; Illemann M; Høyer-Hansen G; Christensen IJ; Hostmark J; Litlekalsoy J; von der Maase H; Pappot H; Laerum OD
    Urol Oncol; 2015 Apr; 33(4):165.e15-24. PubMed ID: 25575713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53 protein in Barrett's adenocarcinoma and adenocarcinoma of the gastric cardia and antrum.
    Jovanović I; Todorović V; Milosavljević T; Micev M; Pesko P; Bjelović M; Mouzas Y; Tzardi M
    Vojnosanit Pregl; 2005 Dec; 62(12):879-85. PubMed ID: 16375215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group.
    Wijnhoven BP; Siersema PD; Hop WC; van Dekken H; Tilanus HW
    Br J Surg; 1999 Apr; 86(4):529-35. PubMed ID: 10215831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological characteristics of Barrett's carcinoma, cardia carcinoma type II and distal gastric carcinoma: influence of observed parameters on the five-year postoperative survival of patients].
    Jovanović I; Alempijević T; Milosavljević T; Popović D; Bjelović M; Micev M; Pesko P
    Srp Arh Celok Lek; 2009; 137(5-6):249-54. PubMed ID: 19594065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus.
    Krishnadath KK; Tilanus HW; van Blankenstein M; Bosman FT; Mulder AH
    J Pathol; 1995 Feb; 175(2):175-80. PubMed ID: 7738712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity and patient survival after surgery for gastric and oesophageal cancer.
    Usselmann B; Newbold M; Morris AG; Nwokolo CU
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):903-8. PubMed ID: 11507353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.
    Flucke U; Steinborn E; Dries V; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    Histopathology; 2003 Aug; 43(2):127-34. PubMed ID: 12877727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high-level amplifications.
    Weiss MM; Kuipers EJ; Hermsen MA; van Grieken NC; Offerhaus J; Baak JP; Meuwissen SG; Meijer GA
    J Pathol; 2003 Feb; 199(2):157-65. PubMed ID: 12533828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia.
    Cameron AJ; Souto EO; Smyrk TC
    Am J Gastroenterol; 2002 Jun; 97(6):1375-80. PubMed ID: 12094853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction.
    Koppert LB; Wijnhoven BP; Tilanus HW; Stijnen T; Van Dekken H; Dinjens WN
    Int J Surg Pathol; 2004 Apr; 12(2):117-25. PubMed ID: 15173916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic Features are more Important Prognostic Factors than Primary Tumour Location in Gastro-oesophageal Adenocarcinoma Treated with Preoperative Chemoradiation and Surgery.
    Vošmik M; Laco J; Sirák I; Dvořák J; Lochman P; Hodek M; Malá P; Rejchrt S; Repák R; Leško M; Ferko A; Ryška A; Melichar B; Petera J
    Pathol Oncol Res; 2018 Apr; 24(2):373-383. PubMed ID: 28550507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma.
    Brundler MA; Harrison JA; de Saussure B; de Perrot M; Pepper MS
    J Clin Pathol; 2006 Feb; 59(2):191-5. PubMed ID: 16443737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
    Aratani K; Komatsu S; Ichikawa D; Ohashi T; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Anticancer Res; 2017 Jun; 37(6):3129-3135. PubMed ID: 28551654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen Activation System in Rectal Adenocarcinoma.
    Razik E; Kobierzycki C; Grzegrzolka J; Podhorska-Okolow M; Drag-Zalesinska M; Zabel M; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6009-15. PubMed ID: 26504024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus.
    Koss K; Harrison RF; Gregory J; Darnton SJ; Anderson MR; Jankowski JA
    J Clin Pathol; 2004 Nov; 57(11):1156-9. PubMed ID: 15509675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Barrett's adenocarcinoma of the gastric cardia with sucrase isomaltase and p53.
    Iannettoni MD; Lee SS; Bonnell MR; Sell TL; Whyte RI; Orringer MB; Beer DG
    Ann Thorac Surg; 1996 Nov; 62(5):1460-5; discussion 1465-6. PubMed ID: 8893584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.